Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
HEALTH
Dengue Fever Vaccine Suspension Criticized by Drugmaker Sanofi
By Cherella Cox
Dec 12, 2017 10:02 AM EST
HEALTH
Dengue Fever Vaccine Suspension Criticized by Drugmaker Sanofi
By Cherella Cox
Dec 12, 2017 10:02 AM EST
VIDEO
Round-Up of Friday's Earnings Reports
By TheStreet Staff
Apr 28, 2017 6:56 AM EDT
STOCKS
Sanofi Shares Hit Highest Mark Since 2015 Following Strong First Quarter
By Paul Whitfield
Apr 28, 2017 5:55 AM EDT
INVESTING
What to Expect From European Pharmaceuticals' First Quarter Results
By Paul Whitfield
Apr 21, 2017 5:44 AM EDT
STOCKS
U.S. and European markets are heading for a fall: Exane BNP
By Paul Whitfield
Jan 24, 2017 7:04 AM EST
MERGERS AND ACQUISITIONS
Actelion is a perfect fit for Sanofi but probably to expensive: Exane BNP
By Paul Whitfield
Dec 7, 2016 9:40 AM EST
STOCKS
Sanofi gains boost from MS treatments as diabetes drug Lantus flounders
By Paul Whitfield
Oct 28, 2016 6:09 AM EDT
STOCKS
What to watch in Sanofi's third-quarter results
By Paul Whitfield
Oct 24, 2016 9:25 AM EDT
OPINION
Pharmacia Drug Sales Dip but Earnings Jump
By Adam Feuerstein
Apr 23, 2002 10:15 AM EDT
